Amgen Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Amgen Inc. AMGN is expected to release earnings results for its second quarter, after the closing bell on Tuesday, Aug. 6.

Analysts expect the Thousand Oaks, California-based company to report quarterly earnings at $5.01 per share, up slightly from $5.00 per share in the year-ago quarter. Amgen is projected to report quarterly revenue of $8.33 billion, compared to $6.99 billion a year earlier, according to data from Benzinga Pro.

On Aug. 2, Amgen declared a $2.25 per share dividend for the third quarter of 2024.

Amgen shares fell 2.6% to close at $325.22 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

• Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and cut the price target from $310 to $303 on July 11. This analyst has an accuracy rate of 72%.
• Argus Research analyst David Toung maintained a Buy rating and boosted the price target from $300 to $340 on June 27. This analyst has an accuracy rate of 70%.
• RBC Capital analyst Gregory Renza maintained an Outperform rating and raised the price target from $328 to $332 on June 14. This analyst has an accuracy rate of 77%.
• BMO Capital analyst Evan David Seigerman maintained an Outperform rating and boosted the price target from $336 to $355 on May 3. This analyst has an accuracy rate of 73%.
• Barclays analyst Carter Gould upgraded the stock from Underweight to Equal-Weight and increased the price target from $230 to $300 on May 3. This analyst has an accuracy rate of 61%.

Read This Next:

• Top 3 Tech Stocks That Could Surge This Quarter